Peer-reviewed veterinary case report
Thai vets' views on CBD for dogs with arthritis
By Osot Nerapusee et al.·Published in Frontiers in Veterinary Science·2023·Department of Social and Administrative Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand, CH·View original on DOAJ →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Thai veterinarians' perceptions of cannabidiol products for dogs with osteoarthritis: a qualitative interview study
- Species:
- dog
Plain-English summary
Veterinarians in Thailand are increasingly considering cannabidiol (CBD) as a treatment option for dogs with osteoarthritis (OA), a condition that causes joint pain and stiffness. While most vets still prefer traditional pain medications like non-steroidal anti-inflammatory drugs (NSAIDs), they recognize the potential benefits of CBD for managing pain and inflammation. However, concerns about product quality and safety remain, with many vets suggesting that CBD should initially be used under their supervision. Overall, there is a positive outlook on CBD, but more research is needed to ensure its effectiveness and safety for dogs with OA.
People also search for: dog osteoarthritis treatment · CBD oil for dogs arthritis · veterinarian opinion on CBD for dogs
Abstract
IntroductionThe global popularity of cannabidiol (CBD) led to its approval for human use in Thailand and potential use in animals. Many studies revealed CBD's efficacy in treating chronic osteoarthritis (OA) in dogs. To facilitate tailored CBD product development for canine OA and ensure market success, this study explores Thai veterinarians' perception of CBD for canine OA.MethodsIn-depth interviews were conducted with experienced veterinarians who treated OA in ≥25% of their canine patients. Interview questions covered treatment, CBD perception, and adoption. Interviews were held from January to March 2023.ResultsEleven out of twenty invited veterinarians participated in the study. Though all favored non-steroidal anti-inflammatory drugs (NSAIDs) for OA in dogs, concerns about adverse reactions, including ulcers and renal failure, emerged. CBD was widely known and was perceived positively for pain, inflammation, cancer, and epilepsy. However, half distinguished CBD from marijuana and tetrahydrocannabinol (THC). Ten expressed willingness to prescribe CBD for OA upon robust clinical evidence. Worries centered on product consistency and impurities. Many suggested CBD should be under veterinarians' supervision at first, but this can be relaxing once safety and efficacy are established. CBD products should be chewable tablets, oils, or gelatin capsules with flavors like beef, liver, pork, fish, or seafood.ConclusionThough CBD benefits were recognized, knowledge gaps among the participants persisted, warranting robust CBD safety, efficacy, and quality evidence to ensure Thai market success. Comprehensive education, including continuing education for those in practice and incorporating CBD-related topics into the Schools of Veterinary's curriculum, is recommended.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on DOAJ: https://doi.org/10.3389/fvets.2023.1304180